Page last updated: 2024-09-05

tbc-11251 and cardiovascular agents

tbc-11251 has been researched along with cardiovascular agents in 3 studies

Compound Research Comparison

Studies (tbc-11251)	Trials (tbc-11251)	Recent Studies (post-2010) (tbc-11251)	Studies (cardiovascular agents)	Trials (cardiovascular agents)	Recent Studies (post-2010) (cardiovascular agents)
167	32	58	17,645	1,480	6,891

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lüscher, TF; Spieker, LE	1
Clark, L; Crawford, FA; Finklea, L; Harrell, A; Hilton, EJ; Ikonomidis, JS; Leonardi, A; Payne, K; Reeves, S; Spinale, FG; Stroud, RE	1
Biswal, S	1

Reviews

1 review(s) available for tbc-11251 and cardiovascular agents

Article	Year
Will endothelin receptor antagonists have a role in heart failure? The Medical clinics of North America, 2003, Volume: 87, Issue:2 Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome	2003

Article

Year

Will endothelin receptor antagonists have a role in heart failure?

The Medical clinics of North America, 2003, Volume: 87, Issue:2

Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome

2003

Trials

1 trial(s) available for tbc-11251 and cardiovascular agents

Article	Year
Selective endothelin-A receptor inhibition after cardiac surgery: a safety and feasibility study. The Annals of thoracic surgery, 2007, Volume: 83, Issue:6 Topics: Aged; Blood Pressure; Cardiopulmonary Bypass; Cardiovascular Agents; Coronary Artery Bypass; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Feasibility Studies; Humans; Isoxazoles; Male; Middle Aged; Postoperative Period; Pulmonary Artery; Thiophenes; Treatment Outcome; Vascular Resistance	2007

Article

Year

Selective endothelin-A receptor inhibition after cardiac surgery: a safety and feasibility study.

The Annals of thoracic surgery, 2007, Volume: 83, Issue:6

Topics: Aged; Blood Pressure; Cardiopulmonary Bypass; Cardiovascular Agents; Coronary Artery Bypass; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Feasibility Studies; Humans; Isoxazoles; Male; Middle Aged; Postoperative Period; Pulmonary Artery; Thiophenes; Treatment Outcome; Vascular Resistance

2007

Other Studies

1 other study(ies) available for tbc-11251 and cardiovascular agents

Article	Year
Novel cardiovascular drugs in clinical trials. Indian journal of medical sciences, 2010, Volume: 64, Issue:6 Topics: Anticholesteremic Agents; Benzaldehydes; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrinolytic Agents; Humans; Immunologic Factors; Isoxazoles; Lipoxygenase Inhibitors; Metalloendopeptidases; Oxazolidinones; Oximes; Phospholipase A2 Inhibitors; Probucol; Pyrimidines; Quinolines; Thiophenes	2010

Article

Year

Novel cardiovascular drugs in clinical trials.

Indian journal of medical sciences, 2010, Volume: 64, Issue:6

Topics: Anticholesteremic Agents; Benzaldehydes; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Endothelin Receptor Antagonists; Fibrinolytic Agents; Humans; Immunologic Factors; Isoxazoles; Lipoxygenase Inhibitors; Metalloendopeptidases; Oxazolidinones; Oximes; Phospholipase A2 Inhibitors; Probucol; Pyrimidines; Quinolines; Thiophenes

2010